Flow Cytometric Screening for the HLA‐B27 Antigen on Peripheral Blood Lymphocytes

Wilfried H.B.M. Levering1, Kees Sintnicolaas1, Henk Wind2, Herbert Hooijkaas2, Jan W. Gratama2

1 Laboratory for Histocompatibility and Immunogenetics, Sanquin Blood, Bank South West Region, Rotterdam, 2 Erasmus MC, Rotterdam
Publication Name:  Current Protocols in Cytometry
Unit Number:  Unit 6.22
DOI:  10.1002/0471142956.cy0622s33
Online Posting Date:  August, 2005
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

HLA‐B27 is common to the entire group of seronegative spondyloarthropathies, and assessment of HLA‐B27 is of diagnostic importance if any of these diseases are considered. Among the alternatives to traditional typing by the complement‐dependent cytotoxicity assay, flow cytometric HLA‐B27 screening is most widely used in general diagnostic laboratories, as it is simple, rapid, and cost effective. This unit describes screening for HLA‐B27 on peripheral blood lymphocytes using more than one HLA‐B27 monoclonal antibody to detect possible cross‐reactivity with non‐HLA‐B27 antigens. Screening is hampered by the lack of true monospecific anti‐HLA‐B27 monoclonal antibodies. Cross‐reactivities of anti‐HLA‐B27 with other HLA‐B antigens have been reported. The authors recommend use of GS145.2 and FD705 antibodies, as this combination avoids most false‐positive conclusions. Lyse‐and‐wash sample processing is employed. A multiparameter flow methodology is applied. Three to four parameters–forward scatter, side scatter, HLA‐B27 expression, and, in some cases CD3 or B7 expression–are acquired.

Keywords: HLA‐B27; flow cytometry; cross‐reactivity; HLA‐typing; monoclonal antibody

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1:

  Materials
  • Patient blood samples to be screened for HLA‐B27, anticoagulated with acid citrate dextrose or EDTA
  • Positive control: freshly obtained blood sample with known HLA‐B27‐positive HLA‐B typing result
  • Negative control: freshly obtained blood sample with known HLA‐B27‐negative HLA‐B typing result and no cross‐reactivity with the HLA‐B27 MAb used (see )
  • HLA‐B27 Kit (BD Biosciences; optional) containing:
    • Anti‐HLA‐B27‐FITC/CD3‐PE (clones anti‐GS145.2 and SK7, respectively)
    • 10× BD FACS lysing solution
    • Calibration beads
    • HLA‐B27 Kit software (optional)
  • 10× ammonium chloride lysing solution ( appendix 2A) or BD FACS lysing solution (BD Biosciences)
  • Phosphate‐buffered saline (PBS; appendix 2A) containing 0.2% BSA (see recipe)
  • PBS containing 1% (w/v) paraformaldehyde
  • FITC‐conjugated anti‐HLA‐B27 monoclonal antibodies: GS145.2 (BD Biosciences), and FD705 (One Lambda; http://www.onelambda.com); combined use of GS145.2 and FD705 is recommended (see above)
  • FITC‐conjugated mouse IgG2b isotype control MAb (One Lambda)
  • 12 × 75–mm polypropylene tubes
  • Tabletop centrifuge
  • Flow cytometer equipped to detect forward scatter (FS) and side scatter (SS), with a laser emitting at 488 nm and at least two fluorescence detectors, i.e., for fluorescein isothiocyanate (FITC) and phycoerythrin (PE)
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Albrecht, J. and Muller, H.A.G. 1987. HLA‐B27 typing by use of flow cytofluorometry. Clin. Chem. 33:1619‐1623.
   Behrens, M. and Lange, R. 2004. A highly reproducible and economically competitive SNP analysis of several well characterized human mutations. Clin. Lab. 50:305‐316.
   Brewerton, D.A., Caffrey, M., Hart, F.D., James, D.C.O., Nicholls, A., and Sturrock, R.D. 1973. Ankylosing spondylitis and HLA‐B27. Lancet 1:904‐907.
   Chou, S.J., Lai, N.S., Su, J.P., Wu, J.L., and Lan, J.L. 1997. Two color analysis of HLA‐B27 antigen by flow cytometer: A comparative study by conventional microlymphocytotoxicity, DNA genotyping polymerase chain reaction and flow cytometric measurement. J. Clin. Lab. Anal. 11:369‐373.
   Chou, C.T., Tsai, Y.F., Liu, J., Wei, J.C., Liao, T.S., Chen, M.L., and Liu, L.Y. 2001. The detection of the HLA‐B27 antigen by immunomagnetic separation and enzyme‐linked immunosorbent assay: Comparison with a flow cytometric procedure. J. Immunol. Methods 255:15‐22.
   Coates, E. and Darke, C. 1998. Routine HLA‐B27 typing by flow cytometry: Differentiation of the products of HLA‐B*2702, B*2705 and B*2708. Eur. J. Immunogenet. 25:29‐37.
   Coates, E., Rees, T.J., and Darke, C. 2003. An evaluation of Com‐B27, a fluorescein‐conjugated mouse anti‐HLA‐B27 reagent. Eur. J. Immunogenet. 30:271‐274.
   De Waal, L., Van der Horst, A., and Krom, F. 1993. Comparison of three anti‐HLA‐B27 monoclonal antibodies by flow cytometric analysis. In Visuals of the Clinical Histocompatibilty Workshop (P.I. Terasaki, ed), Palm Springs Invitational, Palm Springs, Calif., pp. 39‐40. One Lambda, Canoga Park, Calif.
   Dominguez, O., Coto, E., Martinez‐Navez, E., Choo, S.Y., and Lopez‐Larrea, C. 1992. Molecular typing of HLA‐B27 alleles. Immunogenetics 36:277‐282.
   Faner, R., Casamitjana, N., Colobran, R., Ribera, A., Pujol‐Borrell, R., Palou, E., and Juan, M. 2004. HLA‐B27 genotyping by fluorescent resonance emission transfer (FRET) probes in real‐time PCR. Hum. Immunol. 65:826‐838.
   Fuller, A.A., Rodey, G.E., Parham, P., and Fuller, T.C. 1990. Epitope map of the HLA‐B7 CREG using affinity‐purified human alloantibody probes. Hum. Immunol. 28:306‐325.
   Hoffmann, J.J.M.L. and Janssen, W.C.M. 1997. HLA‐B27 phenotyping with flow cytometry: Further improvement by multiple monoclonal antibodies. Clin. Chem. 43:10;1975‐1981.
   Hulstaert, F., Albrecht, J., Hannet, I., Lancaster, P., Buchner, L., Kunz, J., Falkenrodt, A., Tongio, M., de Keyser, F., Veys, E.M., Noens, L., Mir, N., Costell, C., Becker, R., and Strauss, K. 1994. An optimized method for routine HLA‐B27 screening using flow cytometry. Cytometry 18:21‐29.
   Kravtzoff, R., Canepa, S., Boulanger, M.D., Babault, C., and Chassaigne, M. 1991. Phenotypage HLA B27 par cytometrie de flux. Rev. Fr. Transfus. Hémobiol. 34:131‐137.
   Levering, W., Van den Beemd, R., Te Marvelde, J.G., Van Beers, W.A.M., Hooijkaas, H., and Sintnicolaas, K. 2000. External quality assessment of flow cytometric HLA‐B27 typing. Cytometry 42:95‐105.
   Levering, W.H.B.M., Wind, H., Sintnicolaas, K., Hooijkaas, H., and Gratama, J.W. 2003. Flow cytometric HLA‐B27 screening: Cross‐reactivity patterns of commercially available anti HLA‐B27 monoclonal antibodies with other HLA‐B antigens. Cytometry 54B:28‐38.
   Lingenfelter, B., Fuller, T.C., Hartung, L., Hunter, J., and Wittwer, C. 1995. HLA‐B27 screening by flow cytometry. Cytometry 22:146‐149.
   Mittal, K.K., Mickey, M.R., Singal, D.P., and Terasaki, P.I. 1968. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation 8:913‐927.
   Neumüller, J., Schwartz, D.W.M., Dauber, E., and Mayr, W.R. 1996. Evaluation of four monoclonal antibodies against HLA‐B27 for their reliability in HLA‐B27 typing with flow cytometry (FC): Comparison with the classic microlymphocytotoxic test (MLCT). Cytometry 26:209‐215.
   Olerup, O. 1994. HLA‐B27 typing by a group‐specific PCR amplification. Tissue Antigens 43:253‐256.
   Orr, K., Thomson, G.T.D., and Alfa, M. 1994. Utilization of commercial antisera and flow cytometry in HLA‐B27 typing. Cytometry 18:17‐20.
   Pei, R., Arjomand‐Shamsai, M., Deng, C.T., Cesbron, A., Bignon, J.D., and Lee, J.H. 1993. A monospecific HLA‐B27 fluorescein isothiocyanate‐conjugated monoclonal antibody for rapid, simple and accurate HLA‐B27 typing. Tissue Antigens 41:200‐203.
   Reynolds, W.M., Evans, P.R., Wilson, P.J., Wong, W.M., Darke, C., and Smith, J.L. 1996. Automated routine HLA‐B27 typing by flow cytometry. J. Immunol. Methods 197:1‐5.
   Schwartz, A., Fernández‐Repollet, E., Vogt, R., and Gratama, J.W. 1996. Standardizing flow cytometry: Construction of a standardized fluorescence calibration plot using matching spectral calibrators. Cytometry 26:22‐31.
   Seipp, M.T., Erali, M., Wies, R.L., and Wittwer, C. 2005. HLA‐B27 typing: Evaluation of an allele‐specific PCR melting assay and two flow cytometric antigen assays. Cytometry 63B:10‐15.
   Trapani, J.A., Vaughan, H.A., Sparrow, R.L., Tait, B.D., and McKenzie, I.F.C. 1983. Description of a mouse monoclonal anti‐HLA‐B27 antibody HLA‐ABC‐m3. Hum. Immunol. 7:205‐216.
   Ward, A.M. and Nikaein, A. 1995. Comparison of monoclonal antibodies for flow cytometric analysis of HLA‐B27 antigen. Cytometry 22:65‐69.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library